NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 109 filers reported holding NURIX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333 | -21.3% | 42,371 | 0.0% | 0.02% | -11.1% |
| Q2 2023 | $423 | +18.5% | 42,371 | +5.4% | 0.02% | +5.9% |
| Q1 2023 | $357 | +23.5% | 40,211 | +52.9% | 0.02% | +6.2% |
| Q4 2022 | $289 | -99.9% | 26,304 | +16.4% | 0.02% | -11.1% |
| Q3 2022 | $294,000 | +54.7% | 22,594 | +50.8% | 0.02% | +28.6% |
| Q2 2022 | $190,000 | -49.7% | 14,980 | +14.8% | 0.01% | -70.2% |
| Q4 2021 | $378,000 | -6.7% | 13,053 | -3.4% | 0.05% | -13.0% |
| Q3 2021 | $405,000 | – | 13,513 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
| DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
| Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
| Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
| WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
| Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
| Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
| Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
| AtonRa Partners | 24,227 | $190,424 | 0.40% |
| WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |